News

CSPC Pharmaceutical and AstraZeneca form Biologics Joint Venture

Yuvraj — Thu, 06 Aug 2026 12:04:34 +0000

CSPC Pharmaceutical and AstraZeneca have signed a joint venture contract to establish a new-generation production facility in Shijiazhuang, China. The collaboration focuses on the manufacturing and global supply of mutually agreed biologics drug substances, with capital contributions structured at a 51:49 equity ratio in favor of CSPC Pharmaceutical. The agreement remains subject to customary closing […]

The post CSPC Pharmaceutical and AstraZeneca form Biologics Joint Venture first appeared on World Pharma Today.

Bristol Myers Squibb Expands Strategic AI Partnership with Schrödinger

Yuvraj — Thu, 06 Aug 2026 11:56:27 +0000

Bristol Myers Squibb has expanded its ongoing strategic partnership with Schrödinger through a new agreement to deploy the agentic AI co-scientist platform, Bunsen, across its research operations. Building upon an established collaboration in which Bristol Myers Squibb already utilizes Schrödinger computational tools, this enterprise-wide integration is designed to help scientific teams evaluate drug discovery AI […]

The post Bristol Myers Squibb Expands Strategic AI Partnership with Schrödinger first appeared on World Pharma Today.

O-1A Visa Evidence for Pharma and Biotech Professionals: What Actually Proves Extraordinary Ability

Yuvraj — Tue, 04 Aug 2026 11:11:05 +0000

Important pharmaceutical work is not always publicly visible. A medicinal chemist may design a compound series that becomes central to a development program without being named in a press release. A clinical scientist may reshape an oncology protocol without appearing as the lead author of the resulting paper. A manufacturing specialist may prevent recurring batch […]

The post O-1A Visa Evidence for Pharma and Biotech Professionals: What Actually Proves Extraordinary Ability first appeared on World Pharma Today.

CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months

Yuvraj — Sat, 01 Aug 2026 08:52:49 +0000

The Central Drugs Standard Control Organisation (CDSCO) has announced plans to launch the first phase of a comprehensive end-to-end digital drug regulatory platform within the next 18 months. Designed as a single-window interface for the Indian pharmaceutical industry, the platform aims to streamline regulatory processes, enhance operational efficiency, increase transparency, and simplify compliance oversight across […]

The post CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months first appeared on World Pharma Today.

Resilience and Eli Lilly Expand Strategic Partnership with $750 Million Ohio Manufacturing Investment

Yuvraj — Fri, 31 Jul 2026 12:22:22 +0000

Resilience has announced an expansion of its strategic partnership with Eli Lilly to boost domestic medicine production across the United States. The Cincinnati-based contract development and manufacturing organization and the pharmaceutical giant, which first established their collaboration in 2023, are committing $750 million to expand Resilience’s advanced pharmaceutical manufacturing operations in Ohio. Expanding Manufacturing Capacity […]

The post Resilience and Eli Lilly Expand Strategic Partnership with $750 Million Ohio Manufacturing Investment first appeared on World Pharma Today.

WHO Introduces Global Regulatory Framework for Decarbonizing Pharmaceuticals

Yuvraj — Fri, 31 Jul 2026 11:43:16 +0000

The World Health Organization (WHO) has officially launched the first global framework intended to assist medicines regulators in advancing the development of greener pharmaceuticals while maintaining the highest standards of safety, quality, and efficacy. The document, titled “Towards a greener pharmaceuticals’ regulatory highway: a framework for regulators as enablers of decarbonization,” outlines how regulatory authorities […]

The post WHO Introduces Global Regulatory Framework for Decarbonizing Pharmaceuticals first appeared on World Pharma Today.

Why Operational Resilience is Becoming A Strategic Priority Across Pharmaceutical Facilities

Yuvraj — Fri, 31 Jul 2026 05:54:22 +0000

Every aspect of business continues to evolve as the need to meet operational resilience requirements becomes a greater priority. That can be within businesses moving on from aging business continuity plans in the face of changing markets and operating environments to those adopting organisational flexibility to better compete. Whatever the underlying need for change, operational […]

The post Why Operational Resilience is Becoming A Strategic Priority Across Pharmaceutical Facilities first appeared on World Pharma Today.

TRT Safety: What Current Research Actually Says About Long-Term Use

Yuvraj — Fri, 24 Jul 2026 12:55:30 +0000

Testosterone replacement therapy has spent years caught between two extreme narratives. One side presents TRT as inherently dangerous, with unavoidable risks to the heart, prostate, and overall health. The other treats it like a harmless upgrade that almost any man can use indefinitely. Current research supports neither position. The evidence available in 2026 is more […]

The post TRT Safety: What Current Research Actually Says About Long-Term Use first appeared on World Pharma Today.

Merck Signs Voluntary Licensing Deals for Oral HIV Pill

Yuvraj — Fri, 24 Jul 2026 12:05:28 +0000

Merck has entered into seven voluntary licensing agreements with generic manufacturers to produce and distribute lower-cost versions of alimatravir, its experimental once-monthly oral HIV pill. The royalty-free agreements will cover both public and private sectors across 129 low- and lower-middle-income countries, where a substantial majority of new HIV diagnoses globally occur. Although alimatravir remains in […]

The post Merck Signs Voluntary Licensing Deals for Oral HIV Pill first appeared on World Pharma Today.

Trump Proposes Generic Drug Tariffs to Drive Reshoring Effort

Yuvraj — Thu, 23 Jul 2026 12:44:08 +0000

President Donald Trump announced plans to implement massive generic drug tariffs starting at 100% in August 2028, scaling up to 200% in August 2029, in an effort to incentivize the pharmaceutical industry to move production to the United States. The proposed policy imposes a timeline that extends beyond Trump’s current term in office. Describing the […]

The post Trump Proposes Generic Drug Tariffs to Drive Reshoring Effort first appeared on World Pharma Today.